Thermedical, a Waltham medical equipment company, has received Food & Drug Administration clearance to market its technology for the coagulation and ablation of soft tissue during certain surgical procedures.
FDA clearance “is a significant milestone for Thermedical as it will facilitate our plans to carry out a series of clinical trials to evaluate the efficacy of our system for treating large, solid tumors, including liver cancer,” president Michael G. Curley said Wednesday in a statement.
Thermedical said that substantial preclinical testing of its ablation system was carried out under multiple grants from the National Institutes of Health. Thermedical was also awarded $500,000 by the Massachusetts Life Sciences Center.
Privately held Thermedical was founded by Curley and Patrick S. Hamilton, two alumni of the Hyperthermia Center at the Massachusetts Institute of Technology.
Chris ReidyChris Reidy can be reached at firstname.lastname@example.org.